{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:35:37Z","timestamp":1761824137229},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:p>Supratentorial extraventricular ependymomas (STEEs) are relatively rare ependymomas, and their pathologic and genetic characteristics are still poorly understood. The aim of this study was to determine the histologic, immunohistochemical, and <jats:italic toggle=\"yes\">RELA<\/jats:italic> fusion features, as well as to clarify in more detail the clinical courses of STEEs. Data from a total of 43 patients with STEEs was analyzed retrospectively. The status of <jats:italic toggle=\"yes\">RELA<\/jats:italic> fusion was evaluated using fluorescence in situ hybridization. The expression levels of L1CAM, p65, cyclin D1, and p53 were assessed using immunohistochemistry. Progression-free survival and overall survival were calculated via Kaplan-Meier estimation using the log-rank test. Among all 43 STEEs, 65.1% (28\/43) are positive for <jats:italic toggle=\"yes\">RELA<\/jats:italic> fusion. Interestingly, almost half of the patients with <jats:italic toggle=\"yes\">RELA<\/jats:italic> fusion\u2013positive ependymomas are adults (13\/28), and 89.3% (25\/28) cases are anaplastic ependymomas, which suggests that <jats:italic toggle=\"yes\">RELA<\/jats:italic> fusion testing is necessary in adults with STEEs. We investigated the immunohistochemical status of p65, L1CAM and CCND1 protein expression for their ability to predict <jats:italic toggle=\"yes\">RELA<\/jats:italic> fusion status. <jats:italic toggle=\"yes\">RELA<\/jats:italic> fusion\u2013positive STEEs are frequently associated with expression of p65 (85.2%), L1CAM (85.2%), and CCND1 (81.5%). The accuracy of predicting <jats:italic toggle=\"yes\">RELA<\/jats:italic> fusion status was much higher when the expression of p65 and L1CAM was combined, that is, when both were immunopositive. The status of <jats:italic toggle=\"yes\">RELA<\/jats:italic> fusion, p53 overexpression, and extent of tumor resection are significantly associated with prognosis.<\/jats:p>","DOI":"10.1097\/pas.0000000000001342","type":"journal-article","created":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T04:50:04Z","timestamp":1565239804000},"page":"1674-1681","source":"Crossref","is-referenced-by-count":12,"title":["RELA Fusion in Supratentorial Extraventricular Ependymomas: A Morphologic, Immunohistochemical, and Molecular Study of 43 Cases"],"prefix":"10.1097","volume":"43","author":[{"given":"Leiming","family":"Wang","sequence":"first","affiliation":[{"name":"Pathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Beijing Fengtai Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hainan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pathology, Guangdong Sanjiu Brain Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PeiPei","family":"Wang","sequence":"additional","affiliation":[{"name":"Radiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeliang","family":"Hu","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukui","family":"Wei","sequence":"additional","affiliation":[{"name":"Neurosurgery, Xuanwu Hospital Capital Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Peking University International Hospital, Beijing"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjuan","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of Pathology, Jining People\u2019s Hospital, Jining, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pathology, Guangdong Provincial Peoples Hospital, Guangzhou"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihong","family":"Zhao","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dehong","family":"Lu","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lianghong","family":"Teng","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2019,8,6]]},"reference":[{"key":"R1-20230922","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol"},{"key":"R2-20230922","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1093\/neuonc\/now016","article-title":"Biology and management of ependymomas","volume":"18","author":"Wu","year":"2016","journal-title":"Neuro Oncol"},{"key":"R3-20230922","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ccell.2015.04.002","article-title":"Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups","volume":"27","author":"Pajtler","year":"2015","journal-title":"Cancer Cell"},{"key":"R4-20230922","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nature13109","article-title":"C11orf95-RELA fusions drive oncogenic NF-kappaB signalling in ependymoma","volume":"506","author":"Parker","year":"2014","journal-title":"Nature"},{"key":"R5-20230922","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/neuonc\/now025","article-title":"Supratentorial clear cell ependymomas with branching capillaries demonstrate characteristic clinicopathological features and pathological activation of nuclear factor-kappaB signaling","volume":"18","author":"Figarella-Branger","year":"2016","journal-title":"Neuro Oncol"},{"key":"R6-20230922","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11060-018-2767-y","article-title":"C11orf95-RELA fusions and upregulated NF-KB signalling characterise a subset of aggressive supratentorial ependymomas that express L1CAM and nestin","volume":"138","author":"Malgulwar","year":"2018","journal-title":"J Neurooncol"},{"key":"R7-20230922","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/bpa.12664","article-title":"Diagnostics of pediatric supratentorial RELA ependymomas: integration of information from histopathology, genetics, DNA methylation and imaging","volume":"29","author":"Pages","year":"2019","journal-title":"Brain Pathol"},{"key":"R8-20230922","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.3171\/2017.1.JNS161422","article-title":"Clinical, radiological, and histological features and treatment outcomes of supratentorial extraventricular ependymoma: 14 cases from a single center","volume":"128","author":"Sun","year":"2018","journal-title":"J Neurosurg"},{"key":"R9-20230922","doi-asserted-by":"crossref","first-page":"61860","DOI":"10.18632\/oncotarget.11452","article-title":"Low-dose actinomycin-D treatment re-establishes the tumoursuppressive function of P53 in RELA-positive ependymoma","volume":"7","author":"Tzaridis","year":"2016","journal-title":"Oncotarget"},{"key":"R10-20230922","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/jnen\/nlv009","article-title":"The diagnostic use of immunohistochemical surrogates for signature molecular genetic alterations in gliomas","volume":"75","author":"Tanboon","year":"2016","journal-title":"J Neuropathol Exp Neurol"},{"key":"R11-20230922","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.humpath.2018.04.015","article-title":"H3 K27M-mutant diffuse midline gliomas in different anatomical locations","volume":"78","author":"Wang","year":"2018","journal-title":"Hum Pathol"},{"key":"R12-20230922","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ccr.2011.07.007","article-title":"Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma","volume":"20","author":"Witt","year":"2011","journal-title":"Cancer Cell"},{"key":"R13-20230922","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00401-016-1643-0","article-title":"The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants","volume":"133","author":"Pajtler","year":"2017","journal-title":"Acta Neuropathol"},{"key":"R14-20230922","article-title":"High-grade neuroepithelial tumor with BCOR exon 15 internal tandem duplication-a comprehensive clinical, radiographic, pathologic, and genomic analysis","author":"Ferris","year":"2019","journal-title":"Brain Pathol"},{"key":"R15-20230922","first-page":"95","article-title":"SOX10 and Olig2 as negative markers for the diagnosis of ependymomas: an immunohistochemical study of 98 glial tumors","volume":"31","author":"Svajdler","year":"2016","journal-title":"Histol Histopathol"},{"key":"R16-20230922","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/jnen\/nlw010","article-title":"SOX10 distinguishes pilocytic and pilomyxoid astrocytomas from ependymomas but shows no differences in expression level in ependymomas from infants versus older children or among molecular subgroups","volume":"75","author":"Kleinschmidt-DeMasters","year":"2016","journal-title":"J Neuropathol Exp Neurol"},{"key":"R17-20230922","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/neuros\/nyy239","article-title":"Pediatric supratentorial ependymoma: surgical, clinical, and molecular analysis","volume":"85","author":"Lillard","year":"2018","journal-title":"Neurosurgery"},{"key":"R18-20230922","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s00401-014-1264-4","article-title":"Supratentorial ependymomas of childhood carry C11orf95-RELA fusions leading to pathological activation of the NF-kappaB signaling pathway","volume":"127","author":"Pietsch","year":"2014","journal-title":"Acta Neuropathol"},{"key":"R19-20230922","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1016\/j.celrep.2018.04.099","article-title":"A de novo mouse model of C11orf95-RELA fusion\u2013driven ependymoma identifies driver functions in addition to NF-kappaB","volume":"23","author":"Ozawa","year":"2018","journal-title":"Cell Rep"},{"key":"R20-20230922","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/PAS.0000000000000979","article-title":"Role of immunohistochemistry in the identification of supratentorial C11ORF95-RELA fused ependymoma in routine neuropathology","volume":"43","author":"Gessi","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R21-20230922","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10014-017-0301-0","article-title":"RELA fusion\u2013positive anaplastic ependymoma: molecular characterization and advanced MR imaging","volume":"35","author":"Onishi","year":"2018","journal-title":"Brain Tumor Pathol"},{"key":"R22-20230922","doi-asserted-by":"crossref","first-page":"588","DOI":"10.4132\/jptm.2017.08.10","article-title":"Aggressive supratentorial ependymoma, RELA fusion\u2013positive with extracranial metastasis: a case report","volume":"51","author":"Kim","year":"2017","journal-title":"J Pathol Transl Med"},{"key":"R23-20230922","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/neup.12299","article-title":"C11orf95-RELA fusion present in a primary intracranial extra-axial ependymoma: report of a case with literature review","volume":"36","author":"Nambirajan","year":"2016","journal-title":"Neuropathology"},{"key":"R24-20230922","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s10014-017-0297-5","article-title":"Encouraging option of multi-staged gross total resection for a C11orf-RelA fusion\u2013positive supratentorial anaplastic ependymoma","volume":"34","author":"Nakamura","year":"2017","journal-title":"Brain Tumor Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001342","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T22:51:36Z","timestamp":1695423096000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,6]]},"references-count":24,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001342","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8,6]]}}}